Status report
Get it in writing
The official USPTO status record for ATLANYS, serial 79252818, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
ATLANYSSerial 79252818 · Principal Register
Dead · Cancelled
Owner: NOVARTIS AG
Class 005 - Pharmaceuticals
Filed Dec 12, 2018
Registered Jul 09, 2019
The record shows that ATLANYS is no longer active – it was cancelled on Nov 15 2024 after the underlying International Registration was declared dead, and the U.S. registration on the Principal Register was terminated. The owner listed is NOVARTIS AG, a Swiss Aktiengesellschaft, and the mark was limited to Class 005 covering a long list of pharmaceutical products such as anti‑infectives, anti‑inflammatories, cardiovascular and dermatological medicines, among many others. Because the protection was confined to those pharmaceutical goods, a similar name used for unrelated services (for example, software or apparel) would be far removed from the scope shown here, though a pharma‑related use could raise a meaningful concern. The record contains no opposition, cancellation or court actions, so no enforcement signal appears. I'd treat this as a notable risk if you plan a name in the same drug‑product space, but it doesn’t block every possible use of the word.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.